Multimodal Rehabilitation on Gastric Adenocarcinoma Patients Following Radical D2 Gastrectomy - Trial NCT06419140
Access comprehensive clinical trial information for NCT06419140 through Pure Global AI's free database. This Phase 2 trial is sponsored by Zhejiang Cancer Hospital and is currently Not yet recruiting. The study focuses on Gastric Cancer. Target enrollment is 138 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Standard SOX/XELOX adjuvant chemotherapy plus multimodal rehabilitation
Interventional
drug
Sponsor & Location
Zhejiang Cancer Hospital
Timeline & Enrollment
Phase 2
Jun 01, 2024
Dec 31, 2025
Primary Outcome
Adjuvant chemotherapy completion rate
Summary
This study has established a multidisciplinary rehabilitation team to recruit patients who
 underwent radical D2 gastrectomy in multiple centers and divided them into a rehabilitation
 group and a control group. Intervention will be carried out every time the patients come to
 the hospital for adjuvant chemotherapy and review. The control group uses traditional
 intervention model, and the rehabilitation group uses combined exercise/nutrition/psychology
 rehabilitation intervention.
 
 This study is expected to promote early recovery after gastric cancer surgery through
 multidisciplinary rehabilitation intervention, reduce the occurrence of complications,
 improve patients' tolerance to adjuvant chemotherapy, and improve patients' quality of life,
 and hope to improve the short-term and long-term outcomes of gastric cancer patients.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06419140
Non-Device Trial